Advertisement
ROIV vs XBI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a Hold and XBI is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ROIV’s FA Score shows that 0 FA rating(s) are green while.
- ROIV’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ROIV’s TA Score shows that 4 TA indicator(s) are bullish.
- ROIV’s TA Score: 4 bullish, 4 bearish.
Price Growth
ROIV (@Biotechnology) experienced а -0.97% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.
Reported Earning Dates
ROIV is expected to report earnings on Aug 18, 2025.
Industries' Descriptions
@Biotechnology (+7.85% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| ROIV | XBI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 67% | N/A |
| Stochastic ODDS (%) | 1 day ago 77% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 61% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 70% | 1 day ago 90% |
| Advances ODDS (%) | 3 days ago 71% | 1 day ago 89% |
| Declines ODDS (%) | 1 day ago 73% | 15 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 73% | N/A |
| Aroon ODDS (%) | 1 day ago 68% | 1 day ago 86% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CMU | 3.34 | 0.03 | +0.91% |
| MFS High Yield Municipal Trust | |||
| ACWX | 60.33 | 0.07 | +0.12% |
| iShares MSCI ACWI ex US ETF | |||
| TYG | 41.18 | -0.05 | -0.12% |
| Tortoise Energy Infrastructure Corp | |||
| TPLE | 26.19 | -0.09 | -0.33% |
| Timothy Plan US Large/Mid Cp Cr Enh ETF | |||
| IGHG | 77.59 | -0.35 | -0.45% |
| ProShares Investment Grade—Intr Rt Hdgd | |||
ROIV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.
| Ticker / NAME | Correlation To ROIV | 1D Price Change % | ||
|---|---|---|---|---|
| ROIV | 100% | -0.18% | ||
| IMVT - ROIV | 60% Loosely correlated | +4.63% | ||
| ACLX - ROIV | 53% Loosely correlated | +1.18% | ||
| CRNX - ROIV | 53% Loosely correlated | +0.59% | ||
| KRYS - ROIV | 51% Loosely correlated | +0.53% | ||
| CGON - ROIV | 50% Loosely correlated | +0.23% | ||
More | ||||
XBI and
Correlation & Price change
A.I.dvisor indicates that over the last year, XBI has been closely correlated with IDYA. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if XBI jumps, then IDYA could also see price increases.
| Ticker / NAME | Correlation To XBI | 1D Price Change % | ||
|---|---|---|---|---|
| XBI | 100% | +0.10% | ||
| IDYA - XBI | 71% Closely correlated | -0.09% | ||
| KRYS - XBI | 71% Closely correlated | +0.53% | ||
| CRNX - XBI | 71% Closely correlated | +0.59% | ||
| ROIV - XBI | 70% Closely correlated | -0.18% | ||
| BEAM - XBI | 70% Closely correlated | -0.87% | ||
More | ||||